Business Wire

CES 2020 Wraps: AI and 5G Define the Future of Innovation

11.1.2020 03:50:00 EET | Business Wire | Press release

Share

CES® 2020 wrapped today, following a week filled with over 20,000 product debuts unveiling the future of technology. More than 4,400 exhibiting companies launched their latest tech products to some 170,000 attendees across more than 2.9 million net square feet of exhibit space. From global tech brands to pioneering startups, the innovation at CES 2020 will revolutionize markets and change our world for the better.

“CES 2020 inspired and connected every major industry across the globe,” said Gary Shapiro, president and CEO of the Consumer Technology Association (CTA)TM, owner and producer of CES. “The innovation unveiled at CES 2020 will reshape industries, create jobs, fuel the global economy and improve lives around the world.”

“This week at CES illustrated that every company is truly a tech company,” said Karen Chupka, executive vice president, CES. “Global technology brands blended with non-traditional tech companies to showcase how innovation is furthering business across all markets – setting the stage for the decade ahead.”

Key Themes at CES

CES 2020 featured the entire spectrum of transformative technology that will redefine markets and shift business models, including:

Artificial Intelligence

  • AI was dominant throughout the show floor and will be a ‘key ingredient technology’ over the next decade. Companies debuted their latest AI solutions, including Brunswick, Doosan, John Deere and Kyocera.

5G and Mobile Connectivity

  • CES is the only show where the entire 5G ecosystem – the backbone for connectivity, transportation, augmented and virtual reality, digital health and more – comes together. Carriers and mobile operators, such as Verizon, Sprint, AT&T, Nokia and Ericsson, demonstrated the latest advancements in 5G’s speed, reliability and efficiency.

Non-Traditional Tech Companies at CES

  • Non-traditional companies used CES 2020 as a platform to launch products. Impossible Foods returned to CES 2020, debuting its Impossible Pork; John Deere was featured in the AI & Robotics Marketplace and other companies, such as Bell, Delta Airlines, L’Oreal, NBCUniversal and Proctor & Gamble unveiled how they’re transforming their businesses through technology.

Tech for Good

  • Innovative technologies launched at CES that will change lives and improve our world. Digital health technologies were a major theme, with advancements in digital therapeutics, wearables and remote patient monitoring as digital health addresses real world issues like opioid dependence, mental illness and chronic disease. The Health & Wellness category saw an increase of nearly 25% with more than 135 exhibiting companies at CES 2020, including Humetrix and InBody.
  • The Smart Cities exhibit area expanded by nearly 25% over 2019, with companies and organizations including the Department of Transportation, Hitachi and Siemens, highlighting products that will revitalize economies and help communities survive and thrive.
  • CTA also partnered with the World Bank Group at CES 2020 on a Global Tech Challenge, calling for companies around the world to create solutions focused on three key areas: health, gender inequality and technologies that enable communities to be resilient. The Health Tech Challenge category is accepting applications through February 25 to connect innovators with healthcare providers in East Africa.

Eureka Park

  • CES 2020 was also the world’s largest startup event, with more than 1,200 companies from 46 countries featured within Eureka Park, offering disruptive innovations, attracting investors and big-name brands. Technologies unveiled within Eureka Park include the Oval Home smart sensor that analyzes temperature, light, humidity and movement in the home; Yoganotch, which applies motion capture technology to help users improve poses; and Caregiver Smart Solutions with sensors that track movement and patterns to provide caregivers reassurance and patients with more independence at home.

“CES has the unique ability for startups and young companies to get exposure to major global brands,” said Mara Lewis, Co-Founder and CEO, ID8 Innovation; member, CTA Board of Industry Leaders. “The opportunities for venture funding and growth are incredible here. And the CES 2020 Diversity and Inclusion conference track was mind blowing!”

Diversity and Inclusion

  • CES 2020 had a large focus on Diversity and Inclusion, with new programming and partnerships. The Innovation for All conference program featured chief diversity officers and leaders from Bosch, HP and Walmart, and explored inclusive ways that D&I is contributing to the bottom line, shifting culture, hiring differently and investing in diversity.

Travel and Tourism

  • Delta Airlines was the first airline to keynote at CES. During his address, Delta Air Lines CEO Ed Bastian described the future world of travel through tech, including AI, AR, biometric security, smart incentive programs, and a new Parallel Reality experience, as travel becomes more customized.

Transportation and Vehicle Technology

  • CES 2020 was revved up highlighting the future of transportation. Nine of the world’s leading car manufacturers, including Audi, BMW, Daimler (Mercedes), FCA, Ford, Honda, Hyundai, Nissan and Toyota, and more than 150 vehicle tech exhibitors unveiled the latest in connected cars, self-driving vehicles and concept cars. Products included the Mercedes Vision AVTR concept car, Audi’s AI:ME and the Sony Vision S.

C Space

  • CES brought together content creators, Hollywood, the advertising and music industries, media and leading CMOs to explore the future of brand marketing and entertainment, including streaming services, through the return of C Space. The 2020 program featured more than 60 exhibitors, including AT&T Services, Comcast, Google, HP, Hulu, iHeart, NBC Universal, Pandora, Reddit, Roku, SiriuXM, Snap, Twitch, Turner, Univision and WWE.

Keynotes

The CES stage featured more than 1,100 speakers representing major global industries, including keynotes from Samsung President and CEO of Consumer Electronics Division Mr. Hyun-Suk Kim; Daimler Chairman Ola Källenius; Delta Air Lines CEO Ed Bastian; NBCUniversal Chairman of Advertising and Partnerships Linda Yaccarino; Quibi CEO Meg Whitman and Founder Jeffrey Katzenberg; U.S. Secretary of Transportation Elaine L. Chao; Salesforce Chairman and co-CEO Marc Benioff; Unilever CEO Alan Jope; and Presidential Advisor, Ivanka Trump.

Visit CES.tech/Live to see the CES keynotes, SuperSessions and other conference programs.

“We hosted 40 CEOs and corporate directors here, and over half were attending CES for the very first time,” said Nichole Jordan, Central Region Managing Partner, Grant Thornton; member, CTA Board of Industry Leaders. “As we debriefed, they said this show – this experience – helps them to reimagine their businesses and their futures.”

CES, the world’s largest and most influential tech event, returns to Las Vegas, January 6-9, 2021. Visit CES.tech for product announcements, keynote and session videos, b-roll footage and more.

About CES:

CES® is the largest, most influential tech event in the world – the proving ground for breakthrough technologies and global innovators. This is where the world's biggest brands do business and meet new partners, and the sharpest innovators hit the stage. Owned and produced by the Consumer Technology Association (CTA)®, CES features every aspect of the tech sector. Learn more at CES.tech and follow CES on social.

About Consumer Technology Association:

As North America’s largest technology trade association, CTA® is the tech sector. Our members are the world’s leading innovators – from startups to global brands – helping support more than 18 million American jobs. CTA owns and produces CES® – the largest, most influential tech event in the world. Find us at CTA.tech. Follow us @CTAtech

UPCOMING EVENTS

  • CES 2021
    January 6-9, 2021 – Las Vegas, NV

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Caroline Finnell
cfinnell@CTA.tech
703-907-7649

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Acceleronix, IDEMIA Secure Transactions and Orange Announce Flexible, Single-SKU Manufacturing with Quantum-Safe IFPP4.11.2026 17:44:00 EET | Press release

Orange, one of the world’s leading telecom operators, has joined the global quantum-safe In-Factory Profile Provisioning (IFPP) program, jointly launched by Acceleronix and IDEMIA Secure Transactions at MWC Barcelona in February. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104070181/en/ Acceleronix, IDEMIA Secure Transactions and Orange announce flexible, single-SKU manufacturing with quantum-safe IFPP The program enables device makers to build a single product for every market and connect it to the Orange network before it leaves the factory. Acceleronix and IDEMIA Secure Transactions will demonstrate the solution live at electronica 2026, the international electronics trade fair, at Messe München, Hall C2, Stand 601, from 10 to 13 November. Most connected devices share the same weak spot: provisioning and testing on the production line. In-Factory Profile Provisioning (IFPP) addresses this challenge by enabling conne

U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 16:13:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of disease progression or death compared with standard chemoimmunotherapy. Full results from the MANGROVE study will be presented during the Plenary Scientific Session at the 68th American Society of Hematology (ASH) Annual Meeting on December 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103605806/en/ BeOne Medicines' flagship U.S. manufacturing and clinical R&D facility at the P

Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 16:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstracts at the 2026 American Society of Hematology (ASH) Annual Meeting, to beheld December 12 – 15, 2026, in New Orleans. “Our ASH presentations demonstrate meaningful progress across our Hematology portfolio to advance novel treatment approaches for people with serious hematologic conditions,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "We are particularly encouraged by the continued clinical progress of INCA033989 in myelofibrosis (MF) and essential thrombocythemia (ET) and the data for latarcibart in von Willebrand disease (VWD) - data that support our goal of advancing differentiated medicines with the potential to meaningfully improve outcomes for patients." Details on key data presentations at ASH include: Oral Presentations INCA033989 (mutCALR) In JAK-Inhibitor Naive Patients with Myelof

Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 16:00:00 EET | Press release

Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMware and IBM environments, without having to go through a lengthy individual tender process. Through Rimini Support™, organizations gain access to a support alternative enabling them to significantly reduce their historical support costs, improve service quality and support respons

Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 16:00:00 EET | Press release

Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye